Correct, The company's current valuation is a
Post# of 30027
Posted On: 01/23/2016 12:23:46 PM
Correct,
The company's current valuation is a joke. ESS alone is worth 25 to 50 million. If the company can eliminate the toxics we would see a significant spike.
All we can do now is wait and see, the DX merger is a terrible deal from what we have seen and in my opinion, only seems to prove that Lympro is a failure.
I think by years end with a ESS partner maybe even a elto partner with upfront cash we could see a spike to 2 or 3 dollars. I currently wouldn't put any more of a valuation on this company than that due to managements poor decision track record.
Most of us are stuck waiting till we hear of something significant just like we waited in 2015. If a miracle voucher arrives or some glorious partner rides in on his majestic steed our investment may be saved.
Until then we are going to stay at current pps levels with a few drops to the teens maybe even a bit lower.
The toxic will make sure of that.
WD
The company's current valuation is a joke. ESS alone is worth 25 to 50 million. If the company can eliminate the toxics we would see a significant spike.
All we can do now is wait and see, the DX merger is a terrible deal from what we have seen and in my opinion, only seems to prove that Lympro is a failure.
I think by years end with a ESS partner maybe even a elto partner with upfront cash we could see a spike to 2 or 3 dollars. I currently wouldn't put any more of a valuation on this company than that due to managements poor decision track record.
Most of us are stuck waiting till we hear of something significant just like we waited in 2015. If a miracle voucher arrives or some glorious partner rides in on his majestic steed our investment may be saved.
Until then we are going to stay at current pps levels with a few drops to the teens maybe even a bit lower.
The toxic will make sure of that.
WD
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼